• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Pamidronate disodium injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009 and October 2012

 

October 2012

Summary View

 

ADVERSE REACTIONS

Post-Marketing Experience
  • Orbital inflammation

 

July 2009 

Summary View

 

PRECAUTIONS

Osteonecrosis of the Jaw
  • Osteonecrosis of the jaw (ONJ) has been reported predominantly in cancer patients treated with intravenous bisphosphonates, including pamidronate disodium...

ADVERSE REACTIONS

Post-Marketing Experience
  • description of osteonecrosis of the jaw